1,800 Seconds™ in Health Disparities and Inequities for People of Color Living With Multiple Sclerosis
Released On
November 13, 2024
Expires On
November 13, 2025
Media Type
Internet
Completion Time
30 minutes
Specialty
Ethics, Hospitalist, Neurology, Primary Care
Topic(s)
Multiple Sclerosis
This activity is jointly provided by Postgraduate Institute for Medicine and Catamount Medical Education.
This activity is supported by an independent educational grant from Biogen MA, Inc.
Credit Available
- Physicians — Maximum of 0.5 AMA PRA Category 1 Credits™
- Nurses — Maximum of 0.5 ANCC credits
- Physician Assistants — Maximum of 0.5 AAPA Category 1 CME credits
- IPCE — Maximum of 0.5 Interprofessional Continuing Education (IPCE) credits
- ABPN MOC — ABPN Diplomates may select any CME activity relevant to their practice to count toward ABPN MOC requirements
All other health care professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed to meet the educational needs of neurologists, nurse practitioners, PAs, nurses, and other health care professionals who care for patients with MS.
Program Overview
A focused online module dedicated to recognizing and addressing health disparities and inequities among people of color living with multiple sclerosis (MS).
Learning Objectives
After completing this activity, the participant should be better able to:
- Discuss negative differences in health that are closely linked with social, economic, and environmental disadvantages for people of color living with MS
- Discuss the MS care team’s role in addressing differences in access to or availability of facilities or services that are considered modifiable, associated with social disadvantage, and ethically unfair for people of color living with MS
Faculty
Lilyana Amezcua, MD, MS, FAAN
Associate Professor of Neurology
Division Chief, Multiple Sclerosis and Neuroimmunology
DEIB Champion, Department of Neurology
USC, Keck School of Medicine
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Catamount Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
Credit Designation
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours. Designated for 0.5 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until November 13, 2025. PAs should only claim credit commensurate with the extent of their participation.
Interprofessional Continuing Education
This activity was planned by and for the health care team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credits for learning and change.
ABPN MOC
ABPN Diplomates may select any CME activity relevant to their practice to count toward ABPN MOC requirements.
All other health care professionals completing this course will be issued a statement of participation.
Disclosure of Financial Relationships
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly mitigated according to PIM policy. PIM is committed to providing its learners with high-quality accredited continuing education activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of an ineligible company.
Faculty Disclosures
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity. These relationships have been mitigated:
- Lilyana Amezcua, MD, MS, FAAN
- Grants/Research Support: Bristol Myers Squibb Foundation; Genentech, Inc; MedDay Pharma
- Consulting/Advisory Board: Biogen; EMD Serono Inc; and Novartis AG
The PIM planners and others have nothing to disclose. The Catamount Medical Education planners and others have nothing to disclose.
Our Policy On Privacy
When you participate in a CME activity provided by the Postgraduate Institute for Medicine (“PIM” or “we”), we ask you for your name, degree, affiliation, street address, telephone number, fax number, and email address (the “Information”). We use that Information in the following ways:
We use the Information to grade your posttest and to send you a certificate of completion of the CME activity. If we use a third-party company to grade your posttest and issue certificates of completion, we will give the Information to that company for that purpose only.
For each CME activity that you take, you must complete an evaluation questionnaire. That questionnaire asks if you are willing to participate in a follow-up survey. If you answer yes, we will use your name and contact information to send you the survey.
We may use the Information to invite you to participate in other CME activities that PIM or its affiliates may offer.
On occasion, the commercial supporter of a CME activity will ask us for a list of the people who participated in that activity so that it may document the first level of outcomes-based evaluation in CME (ie, who attended, which medical specialties/practices were represented, how this compares to the target audience, and whether the activity needs to be repeated because significant numbers of the target audience did not attend). In that event, we will provide the supporter with your name, title, and affiliation, but we will request in writing that the supporter not contact you directly for any purpose.
If our company is acquired or merged into another company, we may make the Information available to the new owner/entity to use in the ways described above, to enable it to continue our business.
Any changes to our privacy policy will be posted here immediately.
Instructions for Participation and Credit
There are no fees for participating in and receiving credit for this activity. During the period November 13, 2024, through November 13, 2025, participants must (1) read the learning objectives and faculty disclosures, (2) study the educational activity, (3) complete the posttest by recording the best answer to each question, and (4) complete the evaluation form.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 67% (2 out of 3 answers correct) or better. The estimated time to complete the activity is 30 minutes.
This activity was originally released on November 13, 2024, and is eligible for credit through November 13, 2025.
Course Viewing Requirements
This site is best viewed with an HTML5 compatible browser. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser.
Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and RealNetworks RealOne Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Contact Information
For questions about this activity, please contact Catamount Medical Education at [email protected].